Search
Add Trial
Sign In

A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo in Previously Untreated, Stage IV, Metastatic Non-small Cell Lung Cancer Subjects Whose Tumors Are PD-L1 Positive

  • 26/08/2018
  • 3280
  • Comments Off on KEYNOTE-598 / MK-3475-598

Tags

Read more

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Sign In KANCEL

Please select an account type above.

Account details will be confirmed via email.

Register with us by filling out the form below.
Register with us by filling out the form below.

Reset Your Password